Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review

Citterio, 2001, Steroid side effects and their impact on transplantation outcome, Transplantation, 72, S75 Rizzari, 2012, Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation, Clin J Am Soc Nephrol, 7, 494, 10.2215/CJN.08630811 Chavers, 2009, Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results, Transplantation, 88, 237, 10.1097/TP.0b013e3181ac6833 Pascual, 2012, Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review, Nephrol Dial Transpl, 27, 825, 10.1093/ndt/gfr374 Woodle, 2010, A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation, Clin Transpl, 24, 73, 10.1111/j.1399-0012.2009.01127.x Veenstra, 1999, Incidence and long-term cost of steroid-related side effects after renal transplantation, Am J Kidney Dis, 33, 829, 10.1016/S0272-6386(99)70414-2 Schweizer, 1990, Noncompliance in organ transplant recipients, Transplantation, 49, 374, 10.1097/00007890-199002000-00029 Prasad, 2003, Renal transplant recipient attitudes toward steroid use and steroid withdrawal, Clin Transpl, 17, 135, 10.1034/j.1399-0012.2003.00034.x Pascual, 2009, Steroid avoidance or withdrawal for kidney transplant recipients, Cochrane Database Syst Rev, 1 Pascual, 2010, A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation, Transplantation, 90, 343, 10.1097/TP.0b013e3181e58912 Ponticelli, 1997, A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation Italian Multicentre Study Group for Renal Transplantation (SIMTRe), J Am Soc Nephrol, 8, 638, 10.1681/ASN.V84638 Vítko, 2005, Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study, Transplantation, 80, 1734, 10.1097/01.tp.0000188300.26762.74 Tarantino, 1991, A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation, Transplantation, 52, 53, 10.1097/00007890-199107000-00011 Vincenti, 2008, A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients, Am J Transpl, 8, 307, 10.1111/j.1600-6143.2007.02057.x Rostaing, 2005, Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation, Transplantation, 79, 807, 10.1097/01.TP.0000154915.20524.0A Nematalla, 2007, Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study, Exp Clin Transpl, 5, 673 Kumar, 2005, Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies, Clin Transpl, 19, 61, 10.1111/j.1399-0012.2004.00298.x Vincenti, 2003, Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil, Am J Transpl, 3, 306, 10.1034/j.1600-6143.2003.00005.x Lebranchu, 2002, Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy, Am J Transpl, 2, 48, 10.1034/j.1600-6143.2002.020109.x Mourad, 2004, Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids, Transplantation, 78, 584, 10.1097/01.TP.0000129812.68794.CC Ciancio, 2005, A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring, Transplantation, 80, 457, 10.1097/01.tp.0000165847.05787.08 Abou-Ayache, 2008, CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A, Nephrol Dial Transpl, 23, 2024, 10.1093/ndt/gfm873 Brennan, 2006, Rabbit antithymocyte globulin versus basiliximab in renal transplantation, N Eng J Med, 355, 1967, 10.1056/NEJMoa060068 Noël, 2009, Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients, J Am Soc Nephrol, 20, 1385, 10.1681/ASN.2008101037 Sureshkumar, 2012, Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression, Transplantation, 93, 799, 10.1097/TP.0b013e3182472898 Kasiske, 2000, A meta-analysis of immunosuppression withdrawal trials in renal transplantation, J Am Soc Nephrol, 11, 1910, 10.1681/ASN.V11101910 Pascual, 2004, Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials, Transplantation, 78, 1548, 10.1097/01.TP.0000140969.43761.1F Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, 2009, KDIGO clinical practice guideline for the care of kidney transplant recipients, Am J Transpl, 9, S1 Vanrenterghem, 2005, Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial, Am J Transpl, 5, 87, 10.1111/j.1600-6143.2004.00638.x Sola, 2002, Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil, Transpl Proc, 34, 1689, 10.1016/S0041-1345(02)02983-4 Kandaswamy, 2005, A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients – an interim analysis, Am J Transpl, 5, 1529, 10.1111/j.1600-6143.2005.00885.x Laftavi, 2005, Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety, Surgery, 137, 364, 10.1016/j.surg.2004.10.013 Stevens, 2008, Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report, Transplantation, 85, 1391, 10.1097/TP.0b013e3181722fad Ciancio, 2008, Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up, Transplantation, 86, 67, 10.1097/TP.0b013e3181734b4a Grafals, 2014, Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study, PLOS ONE, 9, e104408, 10.1371/journal.pone.0104408 Vathsala, 2005, Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation, Transplantation, 80, 765, 10.1097/01.tp.0000166921.14670.33 Margreiter, 2008, Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial, Am J Transpl, 8, 1480, 10.1111/j.1600-6143.2008.02273.x Chan, 2011, Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy – an open label, randomized trial, Transplantation, 92, 774, 10.1097/TP.0b013e31822ca7ca Welberry Smith, 2013, Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial, Transplantation, 96, 1082, 10.1097/TP.0b013e3182a64db9 3C Study Collaborative Group, 2014, Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial, Lancet, 384, 1684, 10.1016/S0140-6736(14)61095-3 Delgado, 2009, No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study, Transplantation, 87, 546, 10.1097/TP.0b013e3181949d2e Brokhof, 2014, Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients, Transplantation, 97, 612, 10.1097/TP.0000000000000031 Saull, 2015, Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal, Clin Transpl, 29, 573, 10.1111/ctr.12532 Tanriover, 2015, Induction therapies in live donor kidney transplantation on tacrolimus and mycophenolate with or without steroid maintenance, Clin J Am Soc Nephrol, 10, 1041, 10.2215/CJN.08710814 Woodle, 2008, A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy, Ann Surg, 248, 564, 10.1097/SLA.0b013e318187d1da Hanaway, 2011, Alemtuzumab induction in renal transplantation, N Engl J Med, 364, 1909, 10.1056/NEJMoa1009546 Ciancio, 2011, Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation, Transplantation, 92, 1348, 10.1097/TP.0b013e3182384b21 Bösmüller, 2012, Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial, Ann Transpl, 17, 45, 10.12659/AOT.883693 Ciancio, 2010, Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation, Transpl Proc, 42, 3503, 10.1016/j.transproceed.2010.08.045 Ekberg, 2014, An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation, Transpl Res, 3, 12, 10.1186/2047-1440-3-12 Vanrenterghem, 2000, Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection, Transplantation, 70, 1352, 10.1097/00007890-200011150-00015 Büchler, 2007, Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids, Am J Transpl, 7, 2522, 10.1111/j.1600-6143.2007.01976.x Haririan, 2006, Short-term experience with early steroid withdrawal in African-American renal recipients, Am J Transpl, 6, 2396, 10.1111/j.1600-6143.2006.01477.x Zeng, 2007, Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy, Surgery, 142, 538, 10.1016/j.surg.2007.07.006 Thomas, 2007, Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation, Transplantation, 83, 1509, 10.1097/01.tp.0000263344.53000.a1 Li, 2010, Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation, Transplantation, 90, 1516, 10.1097/TP.0b013e3181fc8937 Wittenhagen, 2014, Long-term experience of steroid-free pediatric renal transplantation: effects on graft function, body mass index, and longitudinal growth, Pediatr Transpl, 18, 35, 10.1111/petr.12186 Clayton, 2011, Steroids and recurrent IgA nephropathy after kidney transplantation, Am J Transpl, 11, 1645, 10.1111/j.1600-6143.2011.03667.x Kukla, 2011, Recurrent glomerulonephritis under rapid discontinuation of steroids, Transplantation, 91, 1386, 10.1097/TP.0b013e31821bf157 Von Visger, 2014, The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression, Clin Transpl, 28, 845, 10.1111/ctr.12389 Refaie, 2011, Alemtuzumab preconditioning allows steroid-calcineurin-free regimen in live-donor kidney transplant, Exp Clin Transpl, 5, 295 Ferguson, 2011, Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients, Am J Transpl, 11, 66, 10.1111/j.1600-6143.2010.03338.x Kirk, 2014, Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors, Am J Transpl, 14, 1142, 10.1111/ajt.12712